Author

Donna L. Capozzi

Observed names: D. Capozzi, Donna Capozzi, Donna L Capozzi

Institution: Hospital of the University of Pennsylvania

Observed institutions: Roswell Park Comprehensive Cancer Center, Cleveland Clinic, Hospital of the University of Pennsylvania, Abramson Cancer Center, University at Buffalo, State University of New York, University of Pennsylvania

OpenAlex ID: A5008032023

Implementation and pharmacoeconomic analysis of a clinical staff pharmacist practice model

2001 · Todd W. Nesbit, Kenneth M. Shermock, et al. · American Journal of Health-System Pharmacy · 140

Improving the Safety of Oral Chemotherapy at an Academic Medical Center

2016 · Nirav N. Shah, Erica Casella, et al. · Journal of Oncology Practice · 36

Development of a Pharmacokinetic and Bayesian Optimal Sampling Model for Individualization of Oral Busulfan in Hematopoietic Stem Cell Transplantation

2006 · Julie M Bullock, Patrick F Smith, et al. · Therapeutic Drug Monitoring · 23

Pembrolizumab in Combination with Pomalidomide and Dexamethasone (PEMBRO/POM/DEX) for Pomalidomide Exposed Relapsed or Refractory Multiple Myeloma

2016 · Lilly Wilson, Adam D. Cohen, et al. · Blood · 13

Implementation of DPYD and UGT1A1 Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial

2025 · Sony Tuteja, Mari Angelica S. Cayabyab, et al. · JCO Precision Oncology · 11

PDF

Alteplase for central catheter clearance: 1 mg/mL versus 2 mg/2 mL

2004 · Jodie M Fink, Donna L Capozzi, et al. · Annals of Pharmacotherapy · 10

CTSA pharmacies: Contribution to research and public health during the COVID-19 pandemic

2021 · Robert B. MacArthur, Ohad S. Bentur, et al. · Journal of Clinical and Translational Science · 6

PDF

Which hematology/oncology patients are high priority for ambulatory clinical pharmacist review? A three-round Delphi survey by the National Comprehensive Cancer Network

2023 · Jennifer P Booth, Julie M Kennerly-Shah, et al. · Journal of Oncology Pharmacy Practice · 2

Comparable outcomes in CLL patients treated with reduced-dose ibrutinib: Results from a multi-center study.

2016 · Colleen Timlin, Rahul Banerjee, et al. · Journal of Clinical Oncology · 2

Implementation of an Approach to Equitable Allocation of SARS-CoV-2 Monoclonal Antibodies for Preexposure Prophylaxis: Experience From a Single Medical Center

2024 · Keith W Hamilton, Elvis Hua, et al. · Open Forum Infectious Diseases · 1

Bayesian Optimal Sampling Model (OSM) For Pharmacokinetic (PK) Individualization of Oral and Intravenous Busulfan (B) Regimens

2003 · J. Bullock, P. F. Smith, et al. · Clinical Pharmacology & Therapeutics · 1

Text intervention to minimize time burden of cancer care (TIME).

2023 · Erin Mary Bange, Kerry Q. Coughlin, et al. · JCO Oncology Practice

PDF

Appropriate prescribing of antiemetics with oral oncolytic therapy: a single center experience

2019 · Connie T. Suen, Mitchell E. Hughes, et al. · Journal of Drug Assessment

Implementation of an internal check of oral oncolytics: a single-center, specialty pharmacy safety initiative

2019 · Mitchell Hughes, Richard Kriska, et al. · Journal of Drug Assessment

PDF

Determining specialty pharmacy FTEs (full-time equivalents) needed in a clinical practice

2019 · Kristina Faucher, Joseph Holton, et al. · Journal of Drug Assessment

PDF

Clinical Outcomes of Venetoclax Therapy in Patients with Relapsed/Refractory (r/r) Non Hodgkin Lymphomas (NHL)

2018 · Mitchell E. Hughes, Daniel J. Landsburg, et al. · Blood

Developing a standardized protocol for the prescription of oral chemotherapy.

2014 · Nirav Niranjan Shah, Donna L. Capozzi, et al. · Journal of Clinical Oncology

A Randomized Controlled Trial of Short- Versus Long-course Vancomycin as a Component of an Antibiotic Regimen for Febrile Neutropenic Autologous Peripheral Blood Progenitor Cell (pbpc) Transplant Recipients.

2000 · R. K. Avery, B. Pohlman, et al. · Transplantation

Works count: 18

Citation count: 245

H-index: 6

I10-index: 6